Geneva Healthcare

genevahealth.com

"Make a real difference in people’s lives and see your career go places with the support from a team that cares for you like family." - Veronica Manion, Chief Executive Geneva Healthcare. Trusted by thousands of kiwis nationwide since 1996, we are a locally owned global organisation working closely with ACC, Ministry of Health, DHBs, GPs and the healthcare industry to support those who are in need due to disability, injury, illness or age.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTH TECHNOLOGY

IXENSOR’S EVELINE·CARE TELEHEALTH EMPOWERING FERTILITY SERVICES TO ASSIST PATIENTS’ CONCEPTIONS WITH AT-HOME TEST MONITORING

iXensor | September 14, 2021

news image

iXensor, the pioneer of mobile health, launches its new Eveline•Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly appreciated by patients for comfortable at-home testing, especially amid the ongoing COVID-19 pandemic globally. Helping couples to conceive all around the world<...

Read More

MEDICAL DEVICES

GENEQUANTUM HEALTHCARE'S TWO NEXT GENERATION BIOCONJUGATE DRUGS, GQ1005 AND GQ1007, HAVE BEEN APPROVED FOR CLINICAL TRIALS IN AUSTRALIA

GeneQuantum Healthcare | May 16, 2022

news image

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Read More

GATES FOUNDATION, WELLCOME, MASTERCARD LAUNCH COVID-19 THERAPEUTICS ACCELERATOR

HIT Consultant | March 13, 2020

news image

The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced the launch of the COVID-19 Therapeutics Accelerator with a committed $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. While antiviral drugs are approved to lessen the severity of seasonal flu and treat HI...

Read More

SENSORS TO GO ARE COMING OF AGE

Healthcare IT News | April 02, 2020

news image

When healthcare experts in Europe started debating whether or not to reimburse digital health applications two years ago, Josef Hecken, a very senior German health politician, said in an interview that health insurance companies should not be obliged to pay for “fun applications”. Hecken is head of the German healthcare system’s governing board for reimbursement decisions (G-BA). He is among those who really has a say on where the money flows in German healthcare. Quotes ...

Read More
news image

HEALTH TECHNOLOGY

IXENSOR’S EVELINE·CARE TELEHEALTH EMPOWERING FERTILITY SERVICES TO ASSIST PATIENTS’ CONCEPTIONS WITH AT-HOME TEST MONITORING

iXensor | September 14, 2021

iXensor, the pioneer of mobile health, launches its new Eveline•Care service, effectively turning the smartphone-based Eveline Ovulation Predictor Kit (OPK) into a telehealth-enabled fertility monitoring system. This telehealth service is anticipated by OB-GYN practitioners and highly appreciated by patients for comfortable at-home testing, especially amid the ongoing COVID-19 pandemic globally. Helping couples to conceive all around the world<...

Read More
news image

MEDICAL DEVICES

GENEQUANTUM HEALTHCARE'S TWO NEXT GENERATION BIOCONJUGATE DRUGS, GQ1005 AND GQ1007, HAVE BEEN APPROVED FOR CLINICAL TRIALS IN AUSTRALIA

GeneQuantum Healthcare | May 16, 2022

GeneQuantum Healthcare Co., Ltd. a global innovative biotechnology company dedicated to the development of bioconjugate drugs, announced that two of the company's bioconjugate drug candidates have won the approval for clinical trials in Australia, further enhancing GeneQuantum's pipelines in the clinical stage. They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugateboth with global intellectual property r...

Read More
news image

GATES FOUNDATION, WELLCOME, MASTERCARD LAUNCH COVID-19 THERAPEUTICS ACCELERATOR

HIT Consultant | March 13, 2020

The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced the launch of the COVID-19 Therapeutics Accelerator with a committed $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. While antiviral drugs are approved to lessen the severity of seasonal flu and treat HI...

Read More
news image

SENSORS TO GO ARE COMING OF AGE

Healthcare IT News | April 02, 2020

When healthcare experts in Europe started debating whether or not to reimburse digital health applications two years ago, Josef Hecken, a very senior German health politician, said in an interview that health insurance companies should not be obliged to pay for “fun applications”. Hecken is head of the German healthcare system’s governing board for reimbursement decisions (G-BA). He is among those who really has a say on where the money flows in German healthcare. Quotes ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us